Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
DSCI > SEC Filings for DSCI > Form 8-K/A on 21-Oct-2016All Recent SEC Filings

Show all filings for DERMA SCIENCES, INC.

Form 8-K/A for DERMA SCIENCES, INC.


21-Oct-2016

Financial Statements and Exhibits


Item 9.01 Financial Statements and Exhibits

(a) Financial Statements of Business Acquired

The audited financial statements for BioD as of December 31, 2015 and 2014 and for the years then ended, and the notes related thereto, are attached hereto as Exhibit 99.2 and are incorporated herein by reference. The unaudited financial statements of BioD as of June 30, 2016 and for the six month periods ended June 30, 2016 and 2015, and the notes related thereto, are attached hereto as Exhibit 99.3 and are incorporated herein by reference.

(b) Pro Forma Financial Information

The unaudited pro forma consolidated balance sheet as of June 30, 2016 of the Company and BioD, and the unaudited pro forma consolidated statements of operations for the year ended December 31, 2015 and the six months ended June 30, 2016 of the Company and BioD, and the notes related thereto, are attached hereto as Exhibit 99.4 and are incorporated herein by reference.

(c) The following exhibits are included with this report:

  Exhibit
   Number      Description

   23.1       Consent of BDO USA, LLP, Independent Auditors
   99.1*       Press Release, dated July 28, 2016
   99.2       Audited consolidated financial statements of BioD, LLC and
               subsidiaries as of December 31, 2015 and 2014 and for each of the
               years then ended, and the notes related thereto.
   99.3       Unaudited consolidated financial statements of BioD, LLC and
               subsidiaries as of June 30, 2016 and for the six month periods
               ended June 30, 2016 and 2015, and the notes related thereto.
   99.4       Unaudited pro forma consolidated balance sheet as of June 30, 2016
               of Derma Sciences, Inc. and BioD, LLC and unaudited pro forma
               consolidated statements of operations for the year ended December
               31, 2015 and the six months ended June 30, 2016 of Derma Sciences,
               Inc. and BioD, LLC, and the notes related thereto.

* Previously filed.

Filed herewith.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DERMA SCIENCES, INC.

By: /s/ John E. Yetter
John E. Yetter, CPA
Executive Vice President, Finance
and Chief Financial Officer
(Principal Financial Officer)

Date: October 21, 2016

  Add DSCI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for DSCI - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.